Literature DB >> 10092522

The proto-oncogene p120(Cbl) is a downstream substrate of the Hck protein-tyrosine kinase.

C J Howlett1, S A Bisson, M E Resek, A W Tigley, S M Robbins.   

Abstract

Hematopoietic cell kinase (Hck) is a member of the Src-family of protein tyrosine kinases. We have found that upon enzymatic activation of Hck by the heavy metal mercuric chloride, there was a rapid increase in the levels of tyrosine phosphorylation of several proteins including the proto-oncogene p120(Cbl). Fibroblasts that are transformed with an activated allele of Hck exhibit constitutive Cbl phosphorylation. Upon Fcgamma receptor activation, a more physiologically relevant extracellular signal, Cbl is tyrosine phosphorylated and the Src-family selective inhibitor, PP1, can prevent this phosphorylation on Cbl. Hck phosphorylates Cbl in vitro and the interaction between Cbl and Hck is direct, requiring Hck's unique, SH3 and SH2 domains for optimal binding. Using a novel estrogen-regulated chimera of Hck we have shown a hormone-dependent association between Hck and Cbl in murine fibroblasts. This work suggests that Cbl serves as a key mediator of Hck induced signalling in hematopoietic cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092522     DOI: 10.1006/bbrc.1999.0427

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to imatinib in a kinase-dependent manner.

Authors:  Teodora Pene-Dumitrescu; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome.

Authors:  Bernard A Liu; Brett W Engelmann; Karl Jablonowski; Katherine Higginbotham; Andrew B Stergachis; Piers D Nash
Journal:  Cell Commun Signal       Date:  2012-09-14       Impact factor: 5.712

3.  A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells.

Authors:  M G Tomlinson; D B Woods; M McMahon; M I Wahl; O N Witte; T Kurosaki; J B Bolen; J A Johnston
Journal:  BMC Immunol       Date:  2001-06-08       Impact factor: 3.615

Review 4.  Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.

Authors:  Ashleigh R Poh; Robert J J O'Donoghue; Matthias Ernst
Journal:  Oncotarget       Date:  2015-06-30

5.  Regulation of p73 by Hck through kinase-dependent and independent mechanisms.

Authors:  Preeti Paliwal; Vegesna Radha; Ghanshyam Swarup
Journal:  BMC Mol Biol       Date:  2007-05-30       Impact factor: 2.946

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.